Assemblée générale Projet OASIS (programme de recherche européen pour optimiser les anticorps conjugués) Gustave Roussy
L'Assemblée générale du 16 février sera l'occasion de présenter des projets et des Communications autour du projet OASIS
Faculté de Médecine Paris-Saclay8h30: Welcoming participants
8h50-9h20: External expert lecture,
09h20-09h50: Project overview, Barbara Pistilli, Project Coordinator, Gustave Roussy
09h50-10h20: Project management & Communication (WP16-20), Laura Lauden and Noémie Corcos,Gustave Roussy
10h20-10h40: Patient Engagement (WP16), Kaustubh Dhurandhar, CPE
10h40-11h: Exploitation (WP17), Jérome Gaborit, GRT
Coffee break
11h30-12h: Clinical Data sets (WP1-WP2), Jerome Lemonnier & Marjorie Mauduit, Unicancer
12h-12h15: Digital pathology predictors of response (WP4), Maria Vakalopoulo, Centrale Supélec
12h15-12h45: Liquid biopsy predictors of response (WP3), Marianne Ouhlen, Gustave Roussy; Marijana Rucevic, Olink; Evi Lianidou, NKUA
12h45-13h00: Predicting ADCs toxicity by proteomics and pharmacodynamics analysis (WP9), Angelo Paci, Gustave Roussy
Lunch Break
14h-14h15: ImmunoPET HER Breast (WP5), Geraldine Gebhardt, Loubna Taraji, Institut Jules Bordet
14h15-14h35: Feasability ImmunoPET TROP-2, Nectin-4 (WP6), and production of radiolabeled Ab and ADC (WP10) Charles Truillet, CEA
14h35-14h50: Characterisation of tumor microenvironment and intrinsic pathways of resistance (WP7- WP8), Guillaume Montagnac, INSERM
14h50-15h05: Generation of PDOs biobank and discovery (WP11-WP12), Mathieu Raul, Orakl and Noémie Corcos, Gustave Roussy
15h05-15h25: AI-multimodal training, evaluation and interpretability (WP13,) External validation of OASIS Score (WP14), Paul-Henry Cournède, CentraleSupélec
Coffee break
16h00-16h30: Closing remarks and next steps, Barbara Pistilli and Noemie Corcos